Literature DB >> 16095790

Schizophrenia and single-carbon metabolism.

Björn Regland1.   

Abstract

Schizophrenic patients generally appear to have a disturbed single-carbon metabolism. Methionine and homocysteine are intermediary metabolites in this metabolic system. In a case-control study of the cerebrospinal fluid, a majority of the patients had elevated methionine and a smaller subgroup had elevated homocysteine. Elevated homocysteine is often explained by folate dependency due to mutations in the gene for methylenetetrahydrofolate reductase (MTHFR). A most encouraging feature of single-carbon metabolism is its potential modification by natural means, such as B-vitamins and antioxidants. The findings point to a new area of schizophrenia research: the role of nutrients and antioxidants for rational prevention and treatment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16095790     DOI: 10.1016/j.pnpbp.2005.06.023

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  12 in total

Review 1.  Mass spectrometry strategies for clinical metabolomics and lipidomics in psychiatry, neurology, and neuro-oncology.

Authors:  Paul L Wood
Journal:  Neuropsychopharmacology       Date:  2013-07-11       Impact factor: 7.853

2.  HDAC1 links early life stress to schizophrenia-like phenotypes.

Authors:  Sanaz Bahari-Javan; Hristo Varbanov; Rashi Halder; Eva Benito; Lalit Kaurani; Susanne Burkhardt; Heike Anderson-Schmidt; Ion Anghelescu; Monika Budde; Roman M Stilling; Joan Costa; Juan Medina; Detlef E Dietrich; Christian Figge; Here Folkerts; Katrin Gade; Urs Heilbronner; Manfred Koller; Carsten Konrad; Sara Y Nussbeck; Harald Scherk; Carsten Spitzer; Sebastian Stierl; Judith Stöckel; Andreas Thiel; Martin von Hagen; Jörg Zimmermann; Antje Zitzelsberger; Sybille Schulz; Andrea Schmitt; Ivana Delalle; Peter Falkai; Thomas G Schulze; Alexander Dityatev; Farahnaz Sananbenesi; André Fischer
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-22       Impact factor: 11.205

3.  Chronic hyperhomocysteinemia increases inflammatory markers in hippocampus and serum of rats.

Authors:  Aline A da Cunha; Andréa G K Ferreira; Samanta O Loureiro; Maira J da Cunha; Felipe Schmitz; Carlos Alexandre Netto; Angela T S Wyse
Journal:  Neurochem Res       Date:  2012-04-08       Impact factor: 3.996

4.  Homocysteine reduces NMDAR desensitization and differentially modulates peak amplitude of NMDAR currents, depending on GluN2 subunit composition.

Authors:  Andrew D Bolton; Marnie A Phillips; Martha Constantine-Paton
Journal:  J Neurophysiol       Date:  2013-07-17       Impact factor: 2.714

5.  Identification of genetic and epigenetic variations in a rat model for neurodevelopmental disorders.

Authors:  Karen M J van Loo; Gerard J M Martens
Journal:  Behav Genet       Date:  2007-09       Impact factor: 2.805

6.  Plasma homocysteine levels in depression and schizophrenia in South Indian Tamilian population.

Authors:  Sunil K Narayan; Arul Verman; Shivanand Kattimani; P H Ananthanarayanan; Chandrasekaran Adithan
Journal:  Indian J Psychiatry       Date:  2014-01       Impact factor: 1.759

Review 7.  Diagnostic and treatment implications of psychosis secondary to treatable metabolic disorders in adults: a systematic review.

Authors:  Olivier Bonnot; Hans Hermann Klünemann; Frederic Sedel; Sylvie Tordjman; David Cohen; Mark Walterfang
Journal:  Orphanet J Rare Dis       Date:  2014-04-28       Impact factor: 4.123

Review 8.  Nutritional interventions for the adjunctive treatment of schizophrenia: a brief review.

Authors:  Megan Anne Arroll; Lorraine Wilder; James Neil
Journal:  Nutr J       Date:  2014-09-16       Impact factor: 3.271

9.  Nicotinic Acid Long-Term Effectiveness in a Patient with Bipolar Type II Disorder: A Case of Vitamin Dependency.

Authors:  Bo H Jonsson
Journal:  Nutrients       Date:  2018-01-27       Impact factor: 5.717

Review 10.  Methylenetetrahydrofolate reductase A1298C genetic variant& risk of schizophrenia: A meta-analysis.

Authors:  Vandana Rai; Upendra Yadav; Pradeep Kumar; Sushil K Yadav; Sanjay Gupta
Journal:  Indian J Med Res       Date:  2017-04       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.